Analysis of clinical parameters as predictor of outcome in sorafenib-treated patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Cho, Ju Yeon [1 ]
Paik, Yong Han [1 ]
Lim, Ho Young [1 ]
Min, Yang Won [1 ]
Gwak, Geum-Youn [1 ]
Choi, Moon Seok [1 ]
Lee, Joon Hyeok [1 ]
Koh, Kwang Cheol [1 ]
Paik, Seung Woon [1 ]
Yoo, Byung Chul [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
556
引用
收藏
页码：462A / 462A
页数：1
相关论文
共 50 条
  • [1] Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma
    Cho, Ju-Yeon
    Paik, Yong-Han
    Lim, Ho Yeong
    Kim, Young Gon
    Lim, Hyo Keun
    Min, Yang Won
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    [J]. LIVER INTERNATIONAL, 2013, 33 (06) : 950 - 957
  • [2] Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
    Personeni, Nicola
    Rimassa, Lorenza
    Pressiani, Tiziana
    Destro, Annarita
    Ligorio, Claudia
    Tronconi, Maria Chiara
    Bozzarelli, Silvia
    Carnaghi, Carlo
    Di Tommaso, Luca
    Giordano, Laura
    Roncalli, Massimo
    Santoro, Armando
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1179 - 1187
  • [3] Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
    Nicola Personeni
    Lorenza Rimassa
    Tiziana Pressiani
    Annarita Destro
    Claudia Ligorio
    Maria Chiara Tronconi
    Silvia Bozzarelli
    Carlo Carnaghi
    Luca Di Tommaso
    Laura Giordano
    Massimo Roncalli
    Armando Santoro
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1179 - 1187
  • [4] Clinical Impact of Additional Interferon Administration on Sorafenib-treated Patients with Recurrent Advanced Hepatocellular Carcinoma
    Doi, Hisakazu
    [J]. HEPATOLOGY, 2014, 60 : 872A - 873A
  • [5] Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
    Gyoengyoesi, Benedek
    Vegh, Eva
    Jaray, Balazs
    Szekely, Eszter
    Fassan, Matteo
    Bodoky, Gyoergy
    Schaff, Zsuzsa
    Kiss, Andras
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (08) : 547 - 555
  • [6] Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
    Minh Phuong Dong
    Masaru Enomoto
    Le Thi Thanh Thuy
    Hoang Hai
    Vu Ngoc Hieu
    Dinh Viet Hoang
    Ayako Iida-Ueno
    Naoshi Odagiri
    Yuga Amano-Teranishi
    Atsushi Hagihara
    Hideki Fujii
    Sawako Uchida-Kobayashi
    Akihiro Tamori
    Norifumi Kawada
    [J]. Scientific Reports, 10
  • [7] Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
    Dong, Minh Phuong
    Enomoto, Masaru
    Thuy, Le Thi Thanh
    Hai, Hoang
    Hieu, Vu Ngoc
    Hoang, Dinh Viet
    Lida-Ueno, Ayako
    Odagiri, Naoshi
    Amano-Teranishi, Yuga
    Hagihara, Atsushi
    Fujii, Hideki
    Uchida-Kobayashi, Sawako
    Tamori, Akihiro
    Kawada, Norifumi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01) : 3392
  • [8] Computed tomography findings of sorafenib-treated hepatic tumors in patients with advanced hepatocellular carcinoma
    Kim, Min Ju
    Choi, Joon-Ii
    Lee, Jong Seok
    Park, Joong-Won
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (07) : 1201 - 1206
  • [9] TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
    Geschwind, Jean-Francois
    Kudo, Masatoshi
    Marrero, Jorge A.
    Venook, Alan P.
    Chen, Xiao-Ping
    Bronowicki, Jean-Pierre
    Dagher, Lucy
    Furuse, Junji
    de Guevara, Laura Ladron
    Papandreou, Christos
    Sanyal, Arun J.
    Takayama, Tadatoshi
    Ye, Sheng-Long
    Yoon, Seung Kew
    Nakajima, Keiko
    Lehr, Robert
    Heldner, Stephanie
    Lencioni, Riccardo
    [J]. RADIOLOGY, 2016, 279 (02) : 630 - 640
  • [10] Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Maeda, Takahiro
    Yokoyama, Masayuki
    Wakamatsu, Toru
    Inoue, Masanori
    Saito, Tomoko
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Yokosuka, Osamu
    Kato, Naoya
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (02) : 332 - 339
12345